Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

Volume: 278, Pages: 82 - 90
Published: Nov 1, 2018
Abstract
Background and aims Some studies suggested that proprotein convertase subtilisin kexin type 9 (PCSK9) is linked to liver steatosis severity and non-alcoholic steatohepatitis (NASH). We aimed to assess whether circulating PCSK9 levels are associated with either liver fat content (LFC) or histological markers of NASH in high-risk patients. Methods We present results from three cross-sectional studies from two French Hospitals: Dijon and Numevox...
Paper Details
Title
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
Published Date
Nov 1, 2018
Volume
278
Pages
82 - 90
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.